Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts

Area of Science:

• Oncology
• Developmental Biology
• Genetics

Background:

• Mutations in the Patched (PTCH) gene are linked to various cancers, including childhood medulloblastoma and rhabdomyosarcoma, and adult basal cell carcinoma.
• The factors determining the diverse tumor types and onset ages associated with PTCH mutations remain unclear.

Purpose of the Study:

• To investigate how the timing and dosage of Patched (PTCH) gene inactivation affect the spectrum of induced tumors.
• To elucidate the mechanisms underlying the age-dependent differences in PTCH-associated tumorigenesis.

Main Methods:

• Utilized conditional Ptch-knockout mouse models to study the effects of gene inactivation at different developmental stages.
• Analyzed tumor formation following prenatal and postnatal monoallelic and biallelic Ptch inactivation.

Main Results:

• Prenatal inactivation of Ptch, particularly heterozygosity, led to rhabdomyosarcoma, associated with the silencing of the remaining wild-type allele.
• Postnatal biallelic Ptch deletion induced basal cell carcinoma precursors in the gastrointestinal tract and mesenteric tumors.
• Monoallelic Ptch mutations induced hamartomatous gastrointestinal cystic tumors, irrespective of inactivation timing.

Conclusions:

• The timing, gene dose, and mode of Ptch inactivation significantly influence tumor type and development.
• Distinct tumorigenic mechanisms underlie childhood and adult PTCH-associated cancers, highlighting unique age-related restrictions in tumor occurrence.
• Understanding these mechanisms may offer therapeutic insights for age-specific cancers.